KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTER

🇸🇦Saudi Arabia
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Comparing Post-Transplant Cyclophosphamide as GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients

First Posted Date
2020-03-19
Last Posted Date
2023-10-05
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
264
Registration Number
NCT04314219
Locations
🇸🇦

King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes

First Posted Date
2020-02-05
Last Posted Date
2022-02-03
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
72
Registration Number
NCT04256369
Locations
🇸🇦

King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Somatostatin in Living Donor Liver Transplantation

First Posted Date
2019-09-27
Last Posted Date
2019-09-27
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
56
Registration Number
NCT04107428

Analgosedative adjuncT keTAmine Infusion iN Mechanically vENTilated ICU Patients

First Posted Date
2019-08-30
Last Posted Date
2021-05-07
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
84
Registration Number
NCT04075006
Locations
🇸🇦

King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC

First Posted Date
2019-03-26
Last Posted Date
2019-03-26
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
108
Registration Number
NCT03890185

Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue

Phase 1
Conditions
Neuroendocrine Tumors
Interventions
Drug: Everolimus
First Posted Date
2018-08-14
Last Posted Date
2018-08-14
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
30
Registration Number
NCT03629847
Locations
🇸🇦

Oncology Centre, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant

Phase 4
Conditions
Hepatitis C
Interventions
Drug: Grazoprevir/Elbasvir
First Posted Date
2017-12-02
Last Posted Date
2017-12-02
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
40
Registration Number
NCT03359746

Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers

Phase 2
Terminated
Conditions
Biliary Tract Cancer
Interventions
Combination Product: FOLFIRINOX
First Posted Date
2017-09-25
Last Posted Date
2024-01-17
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
13
Registration Number
NCT03291899
Locations
🇸🇦

king Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Is Vitamin D2 Treatment-associated Decrease in 25(OH)D3 Level a Reciprocal Phenomena?

First Posted Date
2017-01-27
Last Posted Date
2018-08-13
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
100
Registration Number
NCT03035084
Locations
🇸🇦

King Faisal Specialist Hospital & Research Center, Riyadh, Central, Saudi Arabia

Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer

First Posted Date
2016-09-29
Last Posted Date
2018-08-13
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Target Recruit Count
25
Registration Number
NCT02919878
Locations
🇸🇦

Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy